Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-09

FDA Approved: ADVIL SINUS CONGESTION AND PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approves a supplemental application for Advil Sinus Congestion and Pain (ibuprofen and phenylephrine HCl) from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL SINUS CONGESTION AND PAIN (Ibuprofen; phenylephrine hydrochloride)

Snippet

SUPPL AP for ADVIL SINUS CONGESTION AND PAIN (IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE)